MedTrace Logo

Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension

NCT03945305 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-02-28

No results posted yet for this study

Summary

The purpose of this study is to explore the efficacy and safety of remote ischemic conditioning for essential hypertension in the community population.

Conditions

  • Essential Hypertension

Interventions

DEVICE

Patients are treated with previous antihypertensive treatment plus remote ischemic conditioning.

Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mmHg.

OTHER

Previous antihypertensive treatment

Patients are only treated with previous antihypertensive treatment.

Sponsors & Collaborators

  • Yi Yang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-03-31
Completion
2024-04-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03945305 on ClinicalTrials.gov